The rare disease in a remote town where 'almost everyone is a cousin'

Before Silvana Santos arrived in the little town of Serrinha dos Pintos more than 20 years ago, residents had no idea why so many local children had lost the ability to walk.
The remote town in north-eastern Brazil is home to fewer than 5,000 people, and is where biologist and geneticist Santos identified and named a previously unknown condition: Spoan syndrome.
Caused by a genetic mutation, the syndrome affects the nervous system, gradually weakening the body. It only appears when the altered gene is inherited from both parents.
Santos's research marked the first time the disease had been described anywhere in the world. For this and later work, she was named one of the BBC's 100 most influential women in 2024.
Before Santos arrived, families had no explanation for the illness affecting their children. Today, residents talk confidently about Spoan and genetics.
"She gave us a diagnosis we never had. After the research, help came: people, funding, wheelchairs," says Marquinhos, one of the patients.
Serrinha dos Pintos: a world of its own
Where Santos is from in São Paulo, Brazil's largest and wealthiest city, many of her neighbours were members of the same extended family originally from Serrinha. Many of them were cousins of varying degrees, married to each other.
They told Santos that many of people in their hometown couldn't walk, but that no-one knew why.
One of the neighbours' daughters, Zirlândia, suffered from a debilitating condition: as a child, her eyes moved involuntarily and over time, she lost strength in her limbs and needed to use a wheelchair, requiring help with even the simplest tasks.
Years of investigation would lead Santos and a research team to identify these as symptoms of Spoan syndrome.
They would go on to find 82 other cases worldwide.
At the invitation of her neighbours, Santos visited Serrinha on holiday. She describes her arrival as stepping into "a world of its own" - not just because of the lush scenery and mountain views, but also due to what seemed to be a notable social coincidence.
The more she walked and spoke with locals, the more surprised she was at how common marriages between cousins were.
Serrinha's geographical isolation and little inward migration mean that many of the population are related, making marriage between cousins far more likely and more socially acceptable.
Worldwide, marriages between relatives were estimated at around 10% in the early 2010s. More recent data shows the rate varies widely, from over 50% in countries like Pakistan, to 1-4% in Brazil and less than 1% in the US and Russia. Most children born to pairs of cousins are healthy, experts say.
But these marriages do face a higher risk of a harmful genetic mutation being passed down through the family.
"If a couple is unrelated, the chance of having a child with a rare genetic disorder or disability is about 2–3%. For cousins, the risk rises to 5–6% per pregnancy," explains geneticist Luzivan Costa Reis from Brazil's Federal University of Rio Grande do Sul.
A 2010 study led by Santos showed that more than 30% of couples in Serrinha were related, and a third of them had at least one child with a disability.
Long road to diagnosis
Santos set out to find a diagnosis for the people of Serrinha and she began planning a detailed genetic study, requiring multiple trips and eventually leading to her relocating to the region.
She drove the 1,250 miles (2,000km) to and from São Paulo many times in the early years of her research. She collected DNA samples door-to-door, chatting to locals over coffee and gathering family stories, all the while trying to locate the mutation causing the disease.
What was supposed to be three months of fieldwork turned into years of dedication.
It all led to the publication in 2005 of the team's study revealing the existence of Spoan in the Brazilian hinterland.
Santos's team found that the mutation involves the loss of a small fragment of a chromosome, which causes a gene to overproduce a key protein in brain cells.
"They said it came from Maximiano, a womaniser in our family," recalls farmer Lolô, whose daughter Rejane has Spoan.
Lolô, now 83, married his cousin and never left Serrinha. He still tends cattle and relies on family to care for Rejane, who struggles with daily tasks.
But the genetic mutation behind Spoan is far older than the legend of Old Maximiano: it likely arrived more than 500 years ago with early European settlers in the north-east of Brazil.
"Sequencing studies show strong European ancestry in patients, supporting records of Portuguese, Dutch, and Sephardic Jewish presence in the region," says Santos.
The theory gained strength after two Spoan cases were found in Egypt, and further studies showed that the Egyptian cases also shared European ancestry, pointing to a common origin in the Iberian Peninsula.
"It likely came with related Sephardic Jews or Moors fleeing the Inquisition," says Santos. She believes more cases may exist globally, especially in Portugal.
Understanding the risks
Although there's been little progress toward a cure, tracking patients has brought some change. Rejane recalls how people used to be called "cripples". Now, they're simply said to have Spoan.
Wheelchairs brought not just independence, but also helped prevent deformities - in the past, many with the condition had been left simply lying in bed or on the floor.
As Spoan progresses, physical limitations worsen with age and by 50, nearly all patients become fully dependent on carers.
This is the case for Inés's children, who are among the oldest in Serrinha. Chiquinho, 59, can no longer speak, and Marquinhos, 46, has limited communication abilities.
"It's hard to have a 'special' child. We love them the same, but we suffer for them," says Inés, who is married to a second cousin.
Larissa Queiroz, 25, the niece of Chiquinho and Marquinho, also married a distant relative. She and her husband, Saulo, only discovered their common ancestor after several months of dating.
"In Serrinha dos Pintos, deep down, we're all cousins. We're related to everyone," she says.
Couples like Larissa and Saulo are the focus of a new research project which Santos is also involved in. Backed by Brazil's Ministry of Health, it will screen 5,000 couples for genes linked to serious recessive diseases.
The goal is not to stop cousin marriages, but to help couples understand their genetic risks, says Santos. Now a university professor, she also leads a genetics education centre and works to expand testing in the north-east of Brazil.
Though she no longer lives in Serrinha dos Pintos, every visit feels like coming home.
"It's as if Santos is family," says Inés.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Mail​

29 minutes ago

• Daily Mail​

Scientists reveal how humans will have superpowers by 2030

By 2030, rapid technological advancements are expected to reshape humanity, unlocking abilities once confined to science fiction—from superhuman strength to enhanced senses. Robotic exoskeletons may soon allow people to lift heavy objects with ease, while AI-powered wearables, such as smart glasses and earbuds, could provide real-time information and immersive augmented reality experiences. Healthcare may be revolutionized by microscopic nanobots capable of repairing tissue and fighting disease from within the bloodstream, potentially extending human lifespans. Developers are also working on contact lenses with infrared vision and devices that allow users to "feel" digital objects, paving the way for entirely new ways to experience the world. Tech pioneers like former Google engineer Ray Kurzweil believe these innovations are early steps toward the merging of humans and machines, with brain-computer interfaces offering direct access to digital intelligence. While many of these breakthroughs are already in progress, others remain in the experimental phase, facing significant technical and ethical challenges, including concerns about privacy and safety. Still, some of these futuristic technologies may become reality within the next five years, with the potential to enhance human strength, cognition, and perception in ways never before possible. Superhuman strength Kurzweil, a self-proclaimed futurist, has claimed that the foundation of human immortality will begin in 2030, with man set to merge with machines by 2045. By 2030, robotic exoskeletons could give human beings super strength, either by enabling feats like lifting huge objects in factories or making soldiers stronger on the battlefield. US-based robotics company Sarcos Robotics has already demonstrated a robotic exoskeleton that has a 'strength gain' ratio of 20-to-one. This means that normal people can carry weights of up to 200 pounds over an extended period of time. The suit took 17 years and $175 million to develop. Other exoskeletons, such as German Bionic's 'Exia' exoskeleton, incorporate AI that learns from the wearer's movement, enabling them to lift huge weights without feeling tired. These exoskeletons are already being used by staff in German hospitals. Super-healing and immortality In five years, humans could have tiny 'nanobots' in their bloodstream to keep them healthy, meaning people could recover rapidly from injury and even from diseases such as cancer. Kurzweil has claimed that by 2029, artificial intelligence will become 'superhuman' and that will allow for more technological breakthroughs to follow rapidly. One of the upcoming breakthroughs, according to Kurzweil, will be the development of microscopic nanobots that operate within the bloodstream, maintaining health without the need for constant medical monitoring. In his latest book, The Singularity Is Nearer, Kurzweil forecasts a dramatic transformation in human life after 2029, with essential goods becoming more affordable and people beginning to merge with machines through technologies like brain-computer interfaces, similar to Elon Musk's Neuralink. He also pointed to recent advances in artificial intelligence, including tools like ChatGPT, as evidence that his 2005 predictions are on track, stating that "the trajectory is clear." Super vision Contact lenses that enable wearers to see huge distances or even to beam computer information directly into their eyes could be on sale by 2030. Scientists in China recently developed contact lenses that allow wearers to see in the dark. The new lenses allow wearers to see infrared light, without requiring bulky night-vision goggles. Professor Tian Xue, at the University of Science and Technology of China, said he hopes his work could inspire scientists to create contact lenses that offer people 'super vision.' Enhanced senses Devices that give humans enhanced senses could be on the market, with research by Ericsson, a Swedish multinational networking and telecommunications company, suggesting that digital wristbands could soon give anyone the ability to 'feel' digital objects. Pioneering 'cyborg' designers have already tested devices that give people superhuman senses. Entrepreneur, transhumanist, and self-described cyborg Liviu Babitz created 'Northsense,' which allowed him to sense when he faces magnetic north. Manel Munoz, founder of the Trans Species Society, implanted two 'fins' on top of his head, which enabled him to 'hear' the weather. The sound is transmitted through his skull by bone conduction. Munoz has said he hears the weather through the 'sound of bubbles.' Knowing everything instantly with digital wearables By 2030, AI-enhanced wearables such as earbuds could enable everyone to plug into 'digital superpowers,' with everyone able to receive answers instantly. Meta is already adding AI to Ray-Ban glasses, and Google is designing an operating system for XR (augmented reality and virtual reality). Computer scientist Louis Rosenberg has said that these abilities will emerge from the convergence of AI, augmented reality, and conversational computing. 'They will be unleashed by context-aware AI agents that are loaded into body-worn devices that see what we see, hear what we hear, experience what we experience, and provide us with enhanced abilities to perceive and interpret our world,' Rosenberg explained. 'I refer to this new technological direction as augmented mentality and I predict that by 2030, a majority of us will live our lives with context-aware AI agents bringing digital superpowers into our daily experiences.'

Daily Mail​

an hour ago

• Daily Mail​

Nigel Farage becomes latest MP to cast doubt over Lucy Letby murder conviction

Nigel Farage has added his voice to growing concerns about the safety of Lucy Letby 's murder convictions, saying that he is 'getting more and more doubts'. The Reform UK leader was responding to a powerful article in the Daily Mail by Sir Jeremy Hunt, who was Health Secretary when the babies died at the Countess of Chester Hospital. Sir Jeremy called for an urgent re-examination of the case, saying: 'If Letby really did kill seven babies in their cots and attempted to kill seven more, no punishment short of the death penalty is too harsh. 'But if they were caused by professional shortcomings, we need to know why. 'More than anything else, we need to make sure other families don't have to go through the same tragedy.' He added he had noted the findings of the international panel of paediatric specialists and neonatologists, and had also read a 'wide range of expert concerns about the conduct of the criminal case'. Sir Jeremy said: 'Taken together... this analysis raises serious and credible questions about the evidence presented in court, the robustness of expert testimony and the interpretation of statistical data.' Mr Farage told GB News: 'I'm just beginning to get more and more doubts about that issue.' Since Letby lost her appeal last year a mass of evidence undermining the prosecution's case has been gathered by her new legal team. It has raised questions about the claim the nurse was on duty for every suspicious incident and over the testimony of Dr Dewi Evans, 75, the prosecution's chief expert witness. The Criminal Cases Review Commission, which deals with potential miscarriages of justice, is studying the new material, which includes evidence that Dr Evans changed his mind over how three babies died.

Times

2 hours ago

• Times

I have motor neurone disease — and the fund to find a breakthrough

Tris Dyson knew something was wrong in June 2022 when he could not move his left thumb. Six months later, aged just 44 and with a baby daughter, he was diagnosed with motor neurone disease (MND). The muscles in his body were dying and he would, sooner or later, lose the ability to walk, speak and breathe. 'I was newly engaged. I'd bought a house. Things were going quite well. So to be told the party's over was not brilliant,' recalls Dyson. Today he considers himself 'one of the lucky unlucky ones' as his physical decline is 'relatively slow'. Having being told he had four years to live, Dyson said he is in 'pretty good shape', and thinks the doctor's prediction was wrong. Since his diagnosis, Dyson, now 46, has focused his energies on his day job, which just happens to be organising multimillion-pound prizes for scientific breakthroughs. He is managing director of the Longitude Prize, which was established in 2014 as modern-day version of the original Longitude Prize of 1714. The original prize sought reliable ways of measuring longitude at sea, and it took nearly 50 years to be solved. The modern-day version has run two awards so far: the first, in 2014, to tackle antimicrobial resistance, and the second, launched in 2022, seeks treatments for Alzheimer's. Now, the next prize will target MND; specifically amyotrophic lateral sclerosis (ALS), the most common type, which is the one that Dyson suffers from. On Wednesday, Dyson's organisation, Challenge Works, a subsidiary of Nesta, the UK scientific foundation, will launch a £7.5 million Longitude Prize to find a treatment for ALS. For the next five months, Dyson will seek applications from medical researchers and AI experts all over the world before drawing up a shortlist of 20 teams. These will be whittled down in stages, with tranches of money doled out at each step. 'Prizes are very good when you've got a problem and you don't know where the solutions are going to come from,' Dyson says. 'You award on the basis of success.' The winning team will receive £1 million at the end of the challenge. Dyson hopes other investors or private companies will support the prize over time, offering computational power, for example, to run AI calculations. After that, the aim would be for a big pharmaceutical company to take the research and develop a drug: 'We need to feed them with high-potential, credible targets.' Pharma companies would have 'a huge market, potentially', he says. MND is not as rare as you may think. 'About one in 300 people will get it,' Dyson says. 'It's absolutely extraordinary. But often it appears when somebody is very old and it's part of the end-of-life process.' The Motor Neurone Disease Association estimates that it affects up to 5,000 adults in the UK at any one time. • MND sufferer records voice bank so she can swear at her husband MND is characterised by a breakdown in communication between nerve cells called motor neurones and the body's muscles, with the muscles weakening and wasting away, leading to paralysis. The progress of the disease varies from person to person, with only very limited treatments available and no cure. It is more likely to affect people aged over 50. There is no clear cause for MND, although genetic and environmental factors are thought to play a part. About one in ten people may have a family history which makes them more prone to the disease. Dyson believes there now is an opportune moment to tackle MND because of leaps in our understanding of genomics, and the rise of AI, which can sift through big data to find targets for drugs. Until now, he says, research has been limited and diagnosis is still pretty much the same as it was 100 years ago. 'What's happened in the last 15 years is the basic level of science has gone from being very little to a strong basic level of understanding,' Dyson says. 'The other thing that's happened is a huge amount of patient data has been collected, which we're making available through this prize.' Most of the money that has gone into studying MND has come from donations of patients' families, he adds, and cases such as that of the rugby league player Rob Burrow have raised its profile. Burrow and his former team-mate helped raise £6.8 million for a MND centre, which will open later this year in Leeds. 'It takes your independence away,' explains Dyson. 'It takes your dignity away. Some people manage to rise above it. Rob Burrow is a good example. It's still an unbelievably horrendous thing. And then you ask what treatments are available. There aren't any, which is an unbelievable thing to be told in this day and age.' Solving MND is not where Dyson expected his career to take him. He is not a scientist or medic by training; he studied Geography at UCL, where I first encountered him as an undergraduate, hanging around the ground floor of Ramsay Hall, a hall of residence in Fitzrovia whose main claim to fame is that the band Coldplay met there. After we graduated, I would see Dyson at various parties over the years. One early initiative was running a local currency scheme in Wales; another involved setting up a 'time credits' scheme across the UK that offered rewards to people who volunteered within a community. 'There was no plan,' Dyson says, looking back on his career, which brought him to Nesta in 2012. He has not, thankfully, lost his sense of humour, and talks calmly about the challenges ahead. 'I've got weakness in my arms. I might struggle to pick that up,' he says, reaching out to lift a jug of water —which he does, successfully. 'I'm OK walking. I have some problems typing.' He has not yet moved out of his home in Greenwich, southeast London, which has four flights of stairs, because he does not want to 'inconvenience' his partner, Jenny, and their daughter, now three. 'I'm putting money aside for my family. More than I would otherwise.' The unspoken question, of course, is whether Dyson will live to see the fruits of the prize he has founded. How does he look to the future? 'I'm not thinking too much about that,' he says. 'I think Stephen Hawking was like this. He just ignored it.' Hawking was diagnosed at 21 and died at the age of 76. What does he want people to know about MND, and his prize fund? Dyson pauses. 'We have to bring the timeframe of a treatment forward with this prize. I want people to believe it's solvable, and I think that's true.'